PROFESSSOR JEAN-PIERRE PELLETIER, M.D. is Professor of Medicine, Accredited Member of the Department of Pharmacology, Director and Co-founder of the Osteoarthritis Research Unit at the University of Montreal Hospital Centre (CHUM). The Osteoarthritis Research Unit is one of the most highly renowned and respected facilities of its kind. He is also co-titular head of the Chair in Osteoarthritis at the University of Montreal.Professor Pelletier is an internationally renowned and respected expert in the field of osteoarthritis. His principal research interest lies in understanding the mechanisms involved in the pathophysiology of osteoarthritis in humans and preclinical models, as well as in investigating and developing new therapeutic strategies to counteract the disease through basic and clinical research. He also developed, with his team, new automated magnetic resonance imaging systems for the quantification of knee and hip structural alterations in humans and animals and uses these methodologies in clinical trials. His work in the field of arthritis research has led to a large number of landmark studies and in turn to major breakthroughs and discoveries with regard to the pathophysiology and treatment of musculoskeletal diseases.Winner of several international and national awards and prizes including the Roger Demers award in 2012 and the prestigious King Faisal International Prize for Medicine in 2010. He was inducted as a “Master” of the American College of Rheumatology (ACR) in 2014 and appointed “fellow” by the Canadian Academy of Health Sciences (CAHS) in 2008. The success of his work is also illustrated by the impressive number of publications, over 485, and abstracts (more than 870) in world-renowned, peer-reviewed journals, and numerous guest speaker appearances.
Prof. Bernard Combe is Professor of Rheumatology at Montpellier University, France, and Head of the Bone and Joint Department at Montpellier University Hospital.
He completed his medical education at Montpellier University and was subsequently awarded a research fellowship in clinical immunology at the University of Texas, San Antonio, USA.
Prof. Combe was elected member of the National Board of Universities (Rheumatology) from 1994–2000 and again from 2006, as well as being president from 2010–2013. He is an active member of numerous EULAR and ACR task forces. Prof. Combe is Editor-in-Chief of RMD Open (EULAR / BMJ journal) and of La Lettre du Rhumatologue. In addition, he is a member of the editorial boards of Annals of Rheumatic Diseases, Arthritis and Rheumatism and Joint Bone Spine. Prof. Combe has co-authored more than 315 articles published in international
peer-reviewed journals, and has been a coordinator or main investigator in 131 clinical trials.
Prof. JOHANNE MARTEL-PELLETIER, Ph.D. is Professor of Medicine in the Department of Medicine and Accredited Member of the Department of Pharmacology at the University of Montreal. In 1981, she co-founded with Professor Jean-Pierre Pelletier, the Osteoarthritis Research Unit at the University of Montreal Hospital Centre, which today is world renowned for its research in the field. In 2000, they initiated a University Chair in Osteoarthritis at the University of Montreal and have been appointed titular heads of this Chair.Her research interests lie in the mechanisms involved in the etiology of osteoarthritis, such as joint tissue catabolism and cartilage repair, the molecular and biochemical mechanisms involved during the osteoarthritis process of certain proteases, pro- and anti-inflammatory factors, and growth factors in humans and targeting new therapeutic strategies for the treatment of osteoarthritis. In addition, she is involved in developing systems using magnetic resonance imaging technology for the automatic quantification of structural tissue changes in the human knee and hip.She is an active member of several editorial boards and committees and is a highly respected reviewer for numerous rheumatology and connective tissue journals and governmental and private research funding agencies at national and international levels. She has authored more than 410 publications including journal articles, reviews and book chapters and over 730 abstracts, as well as being guest editor of several journals and editor of four books. In addition, she has been an invited guest speaker at numerous national and international meetings and conferences. She is recipient of several distinguished scientific awards honouring her excellence and outstanding achievements in osteoarthritis research.
Prof. Boulos Haraoui, MD FRCPC is an Associate Professor of Medicine at the Université de Montréal and head of the Clinical Research Unit in Rheumatology at the Centre hospitalier de l’Université de Montréal (CHUM) and the Institut de rhumatologie de Montréal.
Dr Haraoui received his medical degree from St. Joseph University in Beirut, Lebanon. Following his post graduate training in Internal Medicine and Rheumatology at the University of Montreal, he completed a research Fellowship at the Arthritis Branch of the National Institutes of Health in Bethesda, Maryland.
He is a founding member and vice-chairman of the Canadian Rheumatology Research Consortium (CRRC). He also chairs the Canadian Initiative in Outcomes in Rheumatology Care (CIORA), the research granting committee of the CRA
Doctor Haraoui is a Past-Chairman of the Scientific Committee of the Canadian Rheumatology Association.
He was an examiner for the Royal College of Physicians and Surgeons of Canada and a member of the Subspecialty Committee on Rheumatology of the RCPSC. He is also a past chairman of the Laurentian Conference of Rheumatology
Doctor Haraoui serves on several provincial, national and international educational and advisory committees, especially on issues pertaining to the diagnosis and management of rheumatoid arthritis.
Dr. Jordi Monfort Faure Graduated in Medicine at the Universitat Central de Barcelona, Specialty Registrar of Rheumatology, Parc de Salut Mar. Hospital del Mar Barcelona, Master in Biomedical Sciences, Université de Montréal, Profeciency University of McGill. Montreal, Master in hospital management International University of Catalonia, PhD, Universitat Autonòma de Barcelona 2010-2013
He is currently an Associated Professor of Rheumatology Universitat Autònoma de Barcelona
Dr. Flavia Cicuttini is a clinical rheumatologist and epidemiologist in the School of Public Health and Preventive Medicine with a long history of research in the area of musculoskeletal health. A major focus of her work has been on improving the methods for assessing joints using new methods such as magnetic resonance imaging. This has enabled a greater understanding of the mechanisms of early joint disease and has enabled new approaches to the prevention and treatment of arthritis.
Dr. Graeme Jones attended Sydney University graduating with first class honours in Medicine in 1985. He then did training in Internal Medicine and Rheumatology in Sydney and Newcastle. He became a fellow of the Royal Australasian College of Physicians in 1991. While at Newcastle he also did a Masters degree in Clinical Epidemiology. He then moved to the Garvan Institute in Sydney where he completed a doctorate in Osteoporosis Epidemiology in 1994. He is also a fellow of the Australian faculty of Public Health Medicine. Since 1995 he has been in Hobart, Tasmania where he combines clinical practice and research. He is currently Professor of Rheumatology and Epidemiology and Head of the Musculoskeletal Unit at the Menzies Research Institute as well as Head of the Department of Rheumatology at Royal Hobart Hospital. An NHMRC Practitioner Fellowship funds his position. He is also the current Medical Director of the Arthritis Foundation of Australia. He has received grants from competitive and non-competitive sources totalling over $16 million dollars and has published >250 articles primarily on the epidemiology of osteoporosis and osteoarthritis. In more recent years he has concentrated on both industry sponsored and investigator initiated clinical trials. He has received awards and given numerous oral presentations at the annual scientific meetings of the American Society for Bone and Mineral Research, the American College of Rheumatology, OARSI and EULAR. His current research interests are the development of peak bone mass and fracture aetiology in children, genetic and environmental risk factors for osteoarthritis, health promotion, the role of environmental factors such as diet and physical activity in osteoporosis and fractures in the elderly, clinical trials and meta-analysis.
Associate Professor Paul Bird (FRACP, PhD, Grad Dip MRI)
Paul Bird is a Rheumatologist in private practice and a Conjoint A/Professor at the University of New South Wales. In addition to his clinical and university responsibilities, he is the Director of Optimus Clinical Research, a clinical research center undertaking Phase 2, 3 and 4 trials of novel agents for the treatment of rheumatic diseases.
He maintains ongoing participation in research projects examining the application of Magnetic Resonance Imaging (MRI) in inflammatory arthritis and is co-chair of the OMERACT international MRI imaging group. He is a current member of GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis).
Prof. Philip Conaghan MBBS PhD FRACP FRCP is Professor of Musculoskeletal Medicine at the University of Leeds and a Rheumatologist for the Leeds Teaching Hospitals NHS Trust. He is a Senior Investigator for the UK National Institute for Health Research (NIHR) and Deputy Director of the NIHR Leeds Musculoskeletal Biomedical Research Unit. His research spans translational studies through large clinical trials, with major interests in understanding pathogenesis and therapeutic response for common arthritides including osteoarthritis and rheumatoid arthritis. He is a senior executive member of the international outcomes group OMERACT. He was inaugural Chair of the EULAR Standing Committee on Musculoskeletal Imaging and is Past-President of the International Society for Musculoskeletal Imaging in Rheumatology. He is on a number of journal editorial boards, is co-editor of the most recent Oxford Textbook of Rheumatology and has authored over 400 publications as original research, reviews and book chapters.
Stephen Hall trained in rheumatology at the Mayo Clinic. He has been in clinical practice since 1984 and is an Associate Professor of Medicine at Monash University based at Cabrini Health.
He conducts a busy clinical practice and maintains a clinical trials unit. He has published widely in clinical trials in the fields of systemic lupus erythematosus, rheumatoid arthritis, polymyositis, ankylosing spondylitis, psoriatic arthritis and osteoarthritis
Peter Nash is Associate Professor in the Department of Medicine at the University of Queensland, and Director of the Rheumatology Research Unit on the Sunshine Coast.. Dr Nash has Chaired the Professional Affairs Committee and the Therapeutics Committee , and serves on the Scientific Advisory Committee of the Australian Rheumatology Association. He is a former member of the Therapeutics Committee of the Australia and New Zealand Bone and Mineral Society. He remains on the International Steering Committee for GRAPPA.
Dr Nash and his group at the Rheumatology Research Unit have been involved with pivotal registration clinical trials for all modern targeted biologic therapies and osteoporosis therapies. He has published more than 100 peer-reviewed papers and 5 book chapters, and acts as reviewer for a number of journals. His special interests include metabolic bone disease and novel therapeutics.
Kevin Pile is the current Past President of APLAR, having served previously as Secretary-General, Treasurer, and President. He is also a past Secretary of the Australian Rheumatology Association. He is a graduate of the University of Otago, who completed his MD research at the University of Oxford. He has held senior academic positions in the University of Adelaide and James Cook University. He is currently Director of Medicine at Campbelltown Hospital Sydney and Conjoint Professor of Medicine at Western Sydney University. Recent research activities relate to quality of life in gout patients and pharmacokinetic studies of febuxostat with varying renal function.